The integrated stress response pathway controls cytokine production in tissue-resident memory CD4+ T cells

Main

T cell memory is a hallmark of the adaptive immune system that results from the antigen-specific activation, expansion and maintenance of T cells. Antigen-experienced memory T (TM) cells elicit a faster and more potent immune response upon re-exposure to the same antigen and provide superior protection against reinfection than naive T (TN) cells1. Based on their specific homing capacity and effector functions, circulating TM cells can be divided into central memory T (TCM) and effector memory (TEM) cells1. In contrast, tissue-resident memory T (TRM) cells do not recirculate and exhibit long-term persistence at sites of previous infections2,3,4,5,6. TRM cells provide long-term immunity against local reinfections2,3,4,5,6, but they also contribute to immune-mediated inflammatory diseases of the gut7, central nervous system8, skin9,10 and kidney11,12,13. The local production of cytokines by CD4+ TRM cells orchestrates protective tissue immunity against pathogens, but can also promote hyperinflammation and tissue damage in immune-mediated diseases14,15,16,17,18,19.

Under homeostatic conditions, TM cells in nonlymphoid tissues express mRNA encoding effector molecules such as IFNγ and TNF for rapid cytokine production through translation of the already-transcribed mRNA20,21,22,23. Yet, whether different TM cell subsets differentially store cytokine mRNA remains incompletely explored. To address this issue, we combined single-cell RNA sequencing (scRNA-seq) and cellular indexing of transcriptomes and epitopes by sequencing (CITE-seq) to analyze CD3+CD4+ and CD3+CD8+ T cells from renal tissue and matched blood of eight healthy donors (cohort 1, median age 60.5 years (interquartile range (IQR) 55–72), 62.5% male)13. mRNA for type 1 (IFNG, TNF, LTA and CSF2) and type 3 (IL17A, IL17F and IL22) cytokines was detected in CD4+ and CD8+ T cells in the kidney, but was expressed at much lower levels in CD4+ and CD8+ T cells from the blood (Fig. 1a,b and Extended Data Fig. 1a,b). RNA fluorescence in situ hybridization (FISH) analysis detected CD3+ T cells expressing IL17A, IFNG and CSF2 mRNA in healthy kidney tissue (Fig. 1c). Expression of IL17A and IL17F mRNA, and to a lesser degree of CSF2 and TNF mRNA, was higher in CD4+ T cells compared to CD8+ T cells in the kidney (Fig. 1b).

Fig. 1: CD4+ TRM cells express proinflammatory cytokine mRNA without translation under homeostatic conditions.
figure 1

a, Uniform Manifold Approximation and Projection (UMAP) plots showing cytokine scores based on the expression of IL2, IL17A, IL17F, IL22, IFNG, TNF, CSF2 and LTA in CD4+ T cells and CD8+ T cells sorted from the blood and healthy kidney tissue of eight healthy donors (cohort 1). b, Heatmap showing the expression of the cytokine score genes in CD4+ T cells and CD8+ T cells from the blood and healthy kidney of donors in cohort 1. c, Representative images of mRNA FISH for IL17A, IFNG and CSF2 combined with immunofluorescence staining for CD3 in healthy kidney tissue from human donors in cohort 1. Scale bars, 50 μm. The experiment was repeated three times. d, UMAP plot of CD4+ T cells isolated from human healthy kidney tissue (cohort 1), showing the distribution of S1PR1CD44+CD69+ TRM cells, CCR7S1PR1+CD44+ TEM cells, CCR7+S1PR1+CD44+ TCM cells and CD45RA+ TN cells. e, Heatmaps showing the protein expression of CD45RA, CD44, CD62L, CCR7 and CD69 (top) and the mRNA expression of CD44, KLF2, S1PR1, SELL and CCR7 (bottom) in CD4+ TRM, TEM, TCM and TN cells (as in d). f, UMAP plot and violin plot showing cytokine scores in CD4+ TRM, TEM, TCM and TN cells (as in d). g, Heatmap showing the expression of the cytokine score genes in CD4+ TRM, TEM, TCM and TN cells (as in d). h, UMAP plot showing CCL5 mRNA expression in CD4+ TRM, TEM, TCM and TN cells (as in d). i, Representative flow cytometry plot showing the gating strategy of CD4+CD69+ TRM cells and CD4+CD69 non-TRM cells and RT–qPCR analysis showing the expression of IL17A, IFNG and CSF2 mRNA in CD69+CD4+ TRM cells and CD69CD4+ non-TRM cells sorted from the human healthy kidneys (n = 5, cohort 2). j,k, UMAP plots showing CD4+ T cells (left) and violin plots showing cytokine scores in SELLCCR7KLF2 TRM cells, SELLCCR7KLF2+ TEM cells and SELL+CCR7+S1PR1+ TCM cells (middle and right) in colon24 (n = 4) (j) and lung25 (n = 10) (k) (left) from healthy human donors. l, Percentage of polysome (translated) mRNA out of cytoplasmic RNA based on RT–qPCR quantification of IL17A, IFNG, CSF2 and ATF4 transcripts in CD4+ TRM cells isolated from human healthy kidneys and left unstimulated or stimulated with PMA + Iono for 1 h (n = 5). Data are mean + s.e.m. Statistical analysis was performed using a one-way analysis of variance (ANOVA) with Tukey’s multiple comparison test (a,f,j) or unpaired two-tailed t-test with Welch’s correction (i,l); *P < 0.05, **P < 0.01. NS, not significant.

Full size image

Unsupervised clustering of human kidney CD4+ T cells identified CD45RA+ TN, CCR7+S1PR1+CD44+ TCM, CCR7S1PR1+CD44+ TEM and S1PR1CD44+CD69+ TRM cells (Fig. 1d,e and Extended Data Fig. 1c). CD4+ TRM cells were the predominant cellular source of proinflammatory cytokine mRNA (for example, IL17A, IFNG and CSF2) and chemokine mRNA (for example, CCL4, CCL5 and CCL20) (Fig. 1f–h and Extended Data Fig. 1c,d). Quantitative PCR with reverse transcription (RT–qPCR) analysis indicated that IL17A, IFNG and CSF2 mRNA expression was significantly higher in CD69+CD4+ TRM cells compared to CD69CD4+ non-TRM cells isolated from the kidney of five healthy donors (cohort 2, median age 59 years (IQR 55–64), 60% male) (Fig. 1i). To explore whether CD4+ TRM cells from other tissues expressed cytokine mRNA, we analyzed public scRNA-seq datasets for healthy human colon24 and lung25. CD4+SELLCCR7KLF2 TRM cells were detected in the healthy colon (Fig. 1j) and lung (Fig. 1k), and expressed higher levels of cytokine mRNA, such as IFNG, TNF and CSF2, compared to other TM cell populations (Fig. 1j,k and Extended Data Fig. 2a–d). These data showed that CD4+ TRM cells expressed proinflammatory cytokine mRNA in various human tissues under noninflammatory conditions.

Production of inflammatory cytokines might lead to inflammation and immunopathology. In the kidney tissue where CD4+ TRM cells were isolated, we did not observe any signs of active inflammation, such as immune cell infiltration (Extended Data Fig. 3a). To investigate whether cytokine mRNA expression in CD4+ TRM cells led to cytokine production, we isolated CD4+ T cells from the blood and kidney of five healthy donors (cohort 2). These cells were treated with brefeldin A, an inhibitor of vesicle transport between the endoplasmic reticulum and the Golgi apparatus, in the presence or absence of phorbol 12-myristate 13-acetate (PMA) + ionomycin (Iono), which mimic T cell receptor activation, for 6 h. Stimulated kidney CD4+ T cells, but not unstimulated ones, produced interleukin (IL)-17A, interferon (IFN)γ and granulocyte–macrophage colony-stimulating factor (GM-CSF) protein (Extended Data Fig. 3b). To investigate whether expression of proinflammatory cytokine mRNA in T cells gave rise to tissue responses under homeostatic conditions, we analyzed the European Renal cDNA Bank database26, which encompasses kidney biopsies from healthy individuals (living donor kidney transplantation) and from patients with autoimmune kidney diseases, such as anti-neutrophil cytoplasmic antibody-associated glomerulonephritis (ANCA-GN), lupus nephritis and IgA nephropathy. We found high expression of genes induced by IL-17, IFNγ or GM-CSF signaling, such as CXCL1 and CXCL5 (IL-17-responsive genes), CXCL9 and CXCL10 (IFNγ-responsive genes) and CCR2 and CCL22 (GM-CSF-responsive genes) in the kidney tissue from autoimmune kidney disease patients27,28,29 (Extended Data Fig. 3c,d). In contrast, expression of these genes was significantly lower in healthy kidney tissue (Extended Data Fig. 3c,d), suggesting that the kidney does not exhibit a tissue response to cytokines under homeostatic conditions.

To investigate the translation status of the cytokine mRNA in resting CD4+ TRM cells, CD69+CD4+ TRM cells were isolated from healthy human kidney tissue. These cells were left unstimulated or stimulated with PMA + Iono for 1 h and mixed with 2 million NIH/3T3 cells to achieve sufficient cell numbers to identify the border between the translated and untranslated mRNA fractions, referred to as the monosome peak. The cells were lysed and subjected to sucrose gradient centrifugation to separate the translated (polysome) and untranslated mRNA fractions30 for RT–qPCR analysis. We found that only around 20% of IL17A, IFNG and CSF2 mRNA was detected in the translated mRNA fraction in unstimulated CD69+CD4+ TRM cells, whereas approximately 80% was found in the translated mRNA fraction in CD69+CD4+ TRM cells stimulated with PMA + Iono (Fig. 1l), indicating that proinflammatory cytokine mRNAs were not translated in CD69+CD4+ TRM cells at steady state. ATF4 mRNA, which is translated under compromised cap-dependent translation31, was efficiently translated in unstimulated CD69+CD4+ TRM cells (Fig. 1l), indicating that the translation of cytokine mRNAs was actively suppressed in CD4+ TRM cells under homeostatic conditions.

Mice maintained under specific-pathogen-free conditions harbor few TRM cells in nonbarrier organs such as the kidney. To perform an in-depth functional analysis of CD4+ TRM cells, we induced kidney TRM cells13, particularly IL-17A-producing TRM (TRM17) cells, by systemically infecting Il17aCreR26eYFP mice32, in which IL-17A-producing cells are labeled with yellow fluorescent protein (YFP), with intravenously injected Staphylococcusaureus. Starting at day 7 post-infection, we treated the mice with antibiotics for 2 weeks to clear the infection. Mice were analyzed 2 months after the end of the antibiotics treatment13,33. We refer to these mice as memory-induced IL-17A reporter mice (hereafter IL-17AMI mice). Immunofluorescence staining combined with mRNA FISH detected numerous CD3+ T cells in the kidney of IL-17AMI mice, with some cells expressing Il17a, Ifng or Csf2 (Fig. 2a). scRNA-seq analysis on YFP+CD4+ T cells sorted from the kidneys of IL-17AMI identified Sell+S1pr1+Klf2+ TCM cell (hereafter CD4+ TCM17 cell), SellS1pr1+Klf2+ TEM cell (CD4+ TEM17 cell) and SellS1pr1Klf2 TRM cell (CD4+ TRM17 cell) subsets (Fig. 2b and Extended Data Fig. 4a). CD4+ TRM17 cells highly expressed mRNA for Il2, Il17a, Il17f, Il22, Ifng, Tnf, Csf2 and Lta, while CD4+ TCM17 cells expressed only Csf2 and CD4+ TEM17 cell expressed only Il22 and Lta (Fig. 2b,c and Extended Data Fig. 4b). RT–qPCR confirmed the higher expression of Il17a mRNA in kidney YFP+CD4+CD44+CD69+CD62L TRM17 cells compared to YFP+CD4+CD44+CD69CD62L TEM17 cells, YFP+CD4+CD44+CD69CD62L+ TCM17 cells, YFPCD4+CD44+CD69+CD62L TRM cells and CD4+CD44 TN cells (Extended Data Fig. 4c). Gene Ontology (GO) pathway analysis indicated that pathways associated with cytoplasmic translation and ribosome biogenesis were significantly downregulated in CD4+ TRM17 cells compared to CD4+ TEM17 cells (Fig. 2d). In the scRNA-seq data of YFP+CD4+ T cells, we observed the coordinated downregulation of ribosomal protein genes (RPGs)34, such as Rpsa, Rps3 and Rpl3 in CD4+ TRM17 cells compared to CD4+ TEM17 cells and CD4+ TCM17 cells (Fig. 2e,f and Extended Data Fig. 4d), indicating the suppression of global mRNA translation in CD4+ TRM17 cells. Moreover, the protein–protein interaction enrichment analysis35 indicated suppression of the ribosomal scanning and start codon recognition processes, which are crucial steps in translation initiation, in CD4+ TRM17 cells compared to CD4+ TEM17 cells and CD4+ TCM17 cells (Extended Data Fig. 4e). These findings indicated that CD4+ TRM17 cells from the kidney of IL-17AMI mice express cytokine mRNA while suppressing mRNA translation under homeostatic conditions.

Fig. 2: Murine TRM cells show downregulated mRNA translation profile under homeostasis with immediate cytokine production ability upon stimulation.
figure 2

a, Representative images of mRNA FISH of Il17a, Ifng and Csf2 mRNA combined with immunofluorescence CD3 staining in the kidney of IL-17AMI mice. Scale bars, 50 μm. The experiment was repeated three times. b, UMAP plots showing the distribution of SellS1pr1Klf2 TRM17 cells, SellS1pr1+Klf2+ TEM17 cells and Sell+S1pr1+Klf2+ TCM17 cells in YFP+CD4+ T cells isolated from the kidneys of IL-17AMI mice and analyzed by scRNA-seq (left) and violin plot showing cytokine scores calculated based on the expression of Il2, Il17a, Il17f, Il22, Ifng, Tnf, Csf2 and Lta in the YFP+CD4+ TRM17, TEM17 and TCM17 cell clusters (middle and right). c, Heatmap showing the expression of Il2, Il17a, Il17f, Il22, Ifng, Tnf, Csf2 and Lta in YFP+CD4+ TRM17, TEM17 and TCM17 cell clusters as in b. d, GO analysis displaying pathways downregulated in YFP+CD4+ TRM17 cells compared to YFP+CD4+ TEM17 cells as in b. e, Violin plot showing the ribosomal protein gene score calculated based on the expression of all RPGs in YFP+CD4+ TRM17, TEM17 and TCM17 cell clusters as in b. f, Volcano plot showing differential gene expression between YFP+CD4+ TRM17 and YFP+CD4+ TEM17 cells as in b. RPGs downregulated in TRM17 cells are shown in orange. g, Time course of IL-17A production in YFP+CD4+CD44+CD69+ TRM17 cells, YFP+CD4+CD44+CD69CD62L TEM17 cells, YFP+CD4+CD44+CD62L+ TCM17 cells and YFPCD4+CD44 TN cells isolated from the kidneys of IL-17AMI mice and stimulated with PMA + Iono for 30 min, 1 h and 3 h (n = 6). h, Representative flow cytometry plots showing IL-17A production in YFP+CD4+CD44+CD69+ TRM17 cells and YFP+CD4+CD44+CD69CD62L TEM17 cells isolated from the kidneys of IL-17AMI mice stimulated with PMA + Iono in the presence or absence of 20 μg ml−1 actinomycin D for 4 h (n = 3). i, Representative flow cytometry plots showing IL-17A production in CD4+CD44+CD69+ TRM cells and CD4+CD44+CD69CD62L TEM cells isolated from the intestine of wild-type C57BL/6 mice stimulated with PMA + Iono in the presence or absence of 20 μg ml−1 actinomycin D for 4 h (n = 4). Data are mean + s.e.m. Statistical analysis was performed using one-way ANOVA with Tukey’s multiple comparison test; **P < 0.01.

Full size image

Rapid production of cytokines by TM cells is crucial for effective host defense. To investigate the kinetics of cytokine production, we stimulated YFP+CD4+CD44+CD69+ TRM17 cells, YFP+CD4+CD44+CD69CD62L TEM17 cells, YFP+CD4+CD44+CD62L+ TCM17 cells and YFPCD4+CD44 TN cells from the kidneys of IL-17AMI mice with PMA + Iono. CD4+ TRM17 cells produced higher levels of IL-17A, IFNγ and GM-CSF at 30 min compared to CD4+ TCM17 cells and CD4+ TEM17 cells (Fig. 2g and Extended Data Fig. 4f). To investigate whether the rapid production of IL-17A in CD4+ TRM17 cells was due to the translation of pre-transcribed mRNA, we stimulated CD4+ TRM17 cells and CD4+ TEM17 cells from the kidneys of IL-17AMI mice with PMA + Iono in the presence or absence of actinomycin D (ActD), which blocks mRNA transcription. CD4+ TRM17 cells and, to a lesser extent, CD4+ TEM17 cells produced IL-17A upon stimulation with PMA + Iono in the absence of ActD (Fig. 2h). When stimulated with PMA + Iono + ActD, CD4+ TRM17 cells (but not CD4+ TEM17 cells) still produced IL-17A protein, although at lower levels than those stimulated with PMA + Iono alone (Fig. 2h). Similar results were observed in CD4+CD44+CD69+ TRM cells and CD4+CD44+CD69CD62L TEM cells from the small intestine of healthy wild-type mice (Fig. 2i). These findings indicated that transcribed Il17a mRNA pools stored in CD4+ TRM cells were sufficient for immediate cytokine protein production upon stimulation.

To understand the molecular pathways that regulated mRNA translation in human CD4+ TRM cells, we analyzed the scRNA-seq dataset of kidney T cells (cohort 1) and published datasets of colon24 and lung25 T cells. GO term pathway analysis and ribosomal protein gene expression analysis revealed the downregulation of translation and ribosome biogenesis pathways in healthy human CD4+ TRM cells isolated from the kidney (Fig. 3a,b and Extended Data Fig. 5a), colon and lung (Extended Data Fig. 5b–e) compared to other healthy human CD4+ TM cell subsets. In contrast, Reactome pathway analysis found upregulation of pathways linked to cellular responses to stress in human kidney CD4+ TRM cells (Fig. 3c). Cellular stress responses are associated with the integrated stress response (ISR) pathway, a biological process activated by various stimuli, such as hypoxia and unfolded protein response31,36. The ISR phosphorylates eIF2α to decrease cap-dependent translation initiation and downregulate global mRNA translation31. Similarly, analysis of the scRNA-seq dataset in the IL-17AMI mice also revealed the downregulation of the start codon recognition and translation initiation process in CD4+ TRM17 cells compared to other CD4+ TM17 cells (Extended Data Fig. 4e). Consistent with these findings, scRNA-seq analysis of human CD4+ T cells from the healthy kidney, colon and lung showed that human CD4+ TRM cells expressed high levels of ISR-associated genes, such as PPP1R15A, ATF3, ATF4 and ATF5 (refs. 31,37,38,39,40,41) (Fig. 3d and Extended Data Fig. 5f–i). eIF2α was phosphorylated in unstimulated human kidney CD4+CD69+ TRM cells, but was dephosphorylated after stimulation of these cells with PMA + Iono for 3 h or CD3+ CD28 Ab for 2 days (Fig. 3f,g and Extended Data Fig. 5j,k). In a puromycin-uptake assay, unstimulated human kidney CD4+CD69+ TRM cells exhibited lower levels of global protein synthesis compared to CD4+CD69+ TRM cells stimulated with PMA + Iono for 2 h (Extended Data Fig. 5l).

Fig. 3: The integrated stress response pathway is activated in human TRM cells.
figure 3

a, GO analysis showing pathways downregulated (left) and upregulated (right) in CD4+SELLS1PR1CD69+ TRM cells compared to CD4+CD69 non-TRM cells isolated from human healthy kidneys (scRNA-seq data of cohort 1 as in Fig. 1d). b, Violin plot showing the ribosomal protein gene score calculated based on the expression of all RPGs in CD4+ TRM, TEM, TCM and TN cell clusters (as in a). c, Reactome analysis displaying pathways upregulated (left) and downregulated (right) in CD4+SELLS1PR1CD69+ TRM cells compared to CD4+CD69 non-TRM cells in human healthy kidneys (as in a). d, Heatmap showing the expression of the ISR-associated genes PPP1R15A, PPP1R15B, ATF3, ATF4, ATF5, ATF6, DDIT3, DNAJB1, DUSP1, FOS, JUN, FOSB and JUNB in CD4+ TRM, TEM, TCM and TN cell clusters (as in a). e, Violin plot showing the ISR-associated gene scores in CD4+ TRM, TEM, TCM and TN cell clusters (as in a). f, Representative immunocytochemistry images of CD4+CD69+ TRM cells sorted from healthy human kidney and stained with antibodies specific for phosphorylated eIF2α (p-eIF2α) and 4,6-diamidino-2-phenylindole (DAPI) and quantification of p-eIF2α expression in CD4+CD69+ TRM cells sorted from healthy human kidney and stimulated or not with PMA + Iono for 3 h (n = 3). Scale bars, 2 μm. g, Representative histogram showing p-eIF2α levels in CD4+CD69+ TRM cells with or without CD3 + CD28 antibody stimulation for 2 days (representative of two experiments). Data are mean + s.e.m. Statistical analysis was performed using one-way ANOVA with Tukey’s multiple comparison test (b,e) or unpaired two-tailed t-test with Welch’s correction (f); *P < 0.05, **P < 0.01.

Full size image

Similar to human CD4+ TRM cells, unstimulated kidney CD4+CD69+ TRM cells from memory-induced wild-type C57BL/6 mice (hereafter WTMI mice) showed high p-eIF2α levels during homeostasis, while following stimulation with PMA + Iono for 3 h or CD3 + CD28 antibody for 2 days, these cells exhibited eIF2α dephosphorylation (Fig. 4a,b and Extended Data Fig. 6a). In CD4+CD69+ TRM cells stimulated with PMA + Iono, global protein synthesis significantly increased compared to unstimulated controls (Extended Data Fig. 6b). In time kinetic experiments using kidney CD4+CD69+ TRM cells from WTMI mice, eIF2α dephosphorylation was observed 15 min after PMA + Iono stimulation (Fig. 4c). Cytokine production was detected 30 min after stimulation (Fig. 4c). p-eIF2α levels were significantly lower in IL-17A- or IFNγ-producing CD4+CD69+ TRM cells stimulated with PMA + Iono compared to unstimulated controls (Extended Data Fig. 6c). Additionally, mouse CD4+CD69+ TRM cells had higher p-eIF2α levels than CD4+CD44+CD69CD62L+ TCM cells, CD4+CD44+CD69CD62L TEM cells and CD4+CD44 TN cells (Extended Data Fig. 6d). Following ISR activation, untranslated mRNAs are sequestered into stress granules, which are membrane-less cytoplasmic organelles30. IL17a mRNA FISH analysis combined with immunocytochemistry for the stress granule marker Tia1 revealed increased colocalization of cytoplasmic Il17a mRNA and Tia1 in unstimulated YFP+CD4+CD69+ TRM cells from IL-17AMI mice compared to YFP+CD4+CD69+ TRM cells stimulated with PMA + Iono for 3 h (Fig. 4d), indicating the release of Il17a mRNA from the stress granules in stimulated TRM cells.

Fig. 4: The integrated stress response pathway regulates cytokine production.
figure 4

a, Representative immunocytochemistry of CD4+CD69+ TRM cells isolated from the kidneys of C57BL/6 WTMI mice and stained with antibodies specific for phosphorylated eIF2α (p-eIF2α) and DAPI, and quantification of p-eIF2α expression in CD4+CD69+ TRM cells isolated from the kidneys of C57BL/6 WTMI mice stimulated or not with PMA + Iono for 3 h (n = 4). Scale bars, 2 μm. b, Representative histogram and quantification of p-eIF2α in CD4+CD69+ TRM cells isolated from the kidneys of WTMI mice and stimulated or not with CD3 + CD28 antibody for 2 days (n = 4). c, Time course plot showing the frequency of IFNγ+ and IL-17A+ in CD4+CD69+ TRM cells and p-eIF2α expression in CD4+CD69+ TRM cells isolated from the kidneys of WTMI mice and stimulated with PMA + Iono for 0, 15, 30 and 60 min (n = 4). d, Representative mRNA FISH for Il17a mRNA combined with immunocytochemistry Tia1 staining in YFP+CD4+CD69+ TRM17 cells sorted from the kidneys of IL-17AMI mice and stimulated or not with PMA + Iono for 3 h (left), and quantification of Il17a mRNA and Tia1 colocalization in YFP+CD4+CD69+ TRM17 cells sorted from the kidneys of IL-17AMI mice and stimulated or not with PMA + Iono for 3 h (right). Scale bars, 2 μm. Quantification of four experiments is shown. e, Expression of p-eIF2α and frequency of IL-17A+ cells in CD4+CD69+ TRM cells isolated from the kidneys of WTMI mice and stimulated with PMA + Iono in the presence of vehicle, 500 μM NaAsO2, 10 μM Sal003, 20 μM Sephin1 or 20 μM Raphin1 for 3 h (n = 4). f, Frequency of IL-17A+ cells in kidney CD4+CD69+ TRM cells (left), glomerular crescent score (middle) and urinary albumin to creatinine ratio (right) in Rag1 KO mice adoptively transferred with eIF2α-S51A+ and eIF2α-S51D+ T cells (n = 6). g, Representative histochemistry images of periodic acid-Schiff (PAS)-stained kidney sections from cGNMI mice treated with vehicle (n = 8) or raphin1 (n = 10) twice a day through oral gavage starting at day 0 of cGN for 10 days until analysis. Arrows indicate glomerular crescents. Scale bars, 50 μm. h, Frequency of crescentic glomeruli and the urinary albumin to creatinine ratio in cGNMI mice treated with vehicle (n = 8) or raphin1 (n = 10) as in g. Data are mean + s.e.m. (*P < 0.05, **P < 0.01). Statistical analysis was performed using one-way ANOVA with Tukey’s multiple comparison test (c,e) or unpaired two-tailed t-test with Welch’s correction (a,b,f,h); *P < 0.05, **P < 0.01. NS, not significant.

Full size image

To investigate the role of the ISR pathway in proinflammatory cytokine production in CD4+CD69+ TRM cells from WTMI mice, we used sodium arsenite, which activates the ISR pathway by oxidative cues30. Sodium arsenite treatment significantly increased eIF2α phosphorylation (Fig. 4e) and suppressed the production of IL-17A, IFNγ and GM-CSF in CD4+CD69+ TRM cells from WTMI mice stimulated with PMA + Iono (Fig. 4f and Extended Data Fig. 6e,f). Sodium arsenite treatment did not affect cell viability or intracellular Ca2+ concentration increase upon T cell stimulation (Extended Data Fig. 6g,h), indicating no signs of toxicity or inhibition of activation. These observations indicated that the ISR controlled the translation of cytokine mRNA.

We next tested whether blocking eIF2α dephosphorylation suppresses cytokine mRNA translation in activated TRM cells. eIF2α is dephosphorylated by the phosphatase complexes PPP1R15A-PP1 and PPP1R15B-PP1 (ref. 31). The pan-eIF2α phosphatase inhibitor Sal003, which blocks both PPP1R15A and PPP1R15B, significantly suppressed eIF2α dephosphorylation and the production of IL-17A, IFNγ and GM-CSF in CD4+CD69+ TRM cells from WTMI mice stimulated with PMA + Iono (Fig. 4e and Extended Data Fig. 6e, f). Sephin1, a selective inhibitor of PPP1R15A, did not suppress eIF2α dephosphorylation or the production of IL-17A, IFNγ and GM-CSF in CD4+CD69+ TRM cells (Fig. 4e and Extended Data Fig. 6e,f). In contrast, raphin1, a selective inhibitor of PPP1R15B, significantly reduced eIF2α dephosphorylation and suppressed the production of those cytokines (Fig. 4e and Extended Data Fig. 6e,f), indicating eIF2α dephosphorylation was predominantly driven by PPP1R15B. None of these compounds suppressed intracellular Ca2+ concentration increase or shedding of surface CD62L upon T cell activation (Extended Data Fig. 6h,i), indicating that T cell activation was not affected. In addition, CD4+CD69+ TRM cells from WTMI mice treated with ISRIB, which binds to and activates eIF2B to facilitate mRNA translation during the ISR, showed a moderate increase in IL-17A and IFNγ production compared to untreated WTMI CD4+CD69+ TRM cells in the absence of TCR stimulation (Extended Data Fig. 6j). We also analyzed CD8+CD69+ TRM cells isolated from the intestine of wild-type C57BL/6 mice. eIF2α was phosphorylated in unstimulated CD8+CD69+ TRM cells, while after stimulation with PMA + Iono for 3 h, CD8+CD69+ TRM cells dephosphorylated eIF2α and produced of IFNγ (Extended Data Fig. 6k). Sodium arsenite treatment increased p-eIF2α levels and inhibited IFNγ production in these cells (Extended Data Fig. 6k). These findings indicated that the ISR pathway might regulate cytokine mRNA translation in CD8+ TRM cells.

To further test whether eIF2α phosphorylation was required for the suppression of cytokine production, we transduced CD4+CD69+ TRM cells from WTMI mice with a constitutively active (eIF2α-S51A) or a constitutively inactive (eIF2α-S51D, a phosphomimetic variant) form of eIF2α42. Production of IL-17A was significantly suppressed in eIF2α-S51D-transduced T cells compared to eIF2α-S51A-trandsuced CD4+CD69+ TRM cells (Fig. 4f), indicating that eIF2α phosphorylation was sufficient to suppress IL-17A production in mouse CD4+CD69+ TRM cells. Next, we transferred either eIF2α-S51D-transduced or eIF2α-S51A-transduced CD4+CD69+ TRM cells into T cell-deficient Rag1 KO mice. One day after transfer, the mice were intraperitoneally injected with nephrotoxic serum to induce autoimmune glomerulonephritis (crescentic GN; cGN)13. At day 10 post-cGN induction, mice that received eIF2α-S51D-transduced CD4+ T cells showed a milder renal disease phenotype, as assessed by glomerular crescent scoring and albuminuria measurement, compared to mice that received eIF2α S51A-transduced CD4+ T cells (Fig. 4f). These findings indicated that targeting the ISR pathway in CD4+ T cells ameliorated tissue inflammation and cGN progression.

To further investigate the therapeutic effects of targeting eIF2α dephosphorylation in autoimmune disease, we induced cGN in WTMI mice (hereafter cGNMI mice) and treated them with raphin1 (ref. 43) via twice-daily oral gavage. At day 10 of cGN, the levels of p-eIF2α in kidney CD4+CD69+ TRM cells were higher in raphin1-treated compared to vehicle-treated cGNMI mice (Extended Data Fig. 7a). Raphin1-treated cGNMI mice exhibited reduced glomerular crescent formation and albuminuria, indicating improved kidney function compared to vehicle-treated cGNMI mice (Fig. 4g,h). Raphin1 treatment did not improve kidney function in nephritic wild-type mice in which CD4+CD69+ TRM cells were not induced by infection (Extended Data Fig. 7b), indicating that CD4+CD69+ TRM cells were required for the therapeutic effect. These findings suggested that targeting the ISR–eIF2α pathway may represent a therapeutic strategy in immune-mediated diseases.

Finally, to explore the relevance of our findings in human autoimmune diseases, we performed scRNA-seq analysis on CD4+ T cells isolated from kidney biopsies of five patients with ANCA-GN (cohort 3, median age 67 years (IQR 61–72), 60% male). We compared these cells with CD4+ T cells from healthy donors (three kidney biopsies from cohort 1, which were processed using the same protocol as the samples from patients with ANCA-GN) (Fig. 5a). The expression levels of mRNA encoding type 1 (for example, IFNG and TNF) and type 3 (for example, IL17A and IL17F) cytokines in S1PR1KLF2CD69+ TRM cells were similar between patients with ANCA-GN and healthy controls (Fig. 5b). Reactome pathway analysis revealed downregulation of the cellular response to stress pathway in kidney CD4+ TRM cells from patients with ANCA-GN compared to kidney CD4+ TRM cells from healthy controls (Fig. 5c). Moreover, kidney CD4+ TRM cells from patients with ANCA-GN exhibited significantly lower expression of ISR-associated genes (for example, PPP1R15A, PPP1R15B, ATF3 and ATF4) compared to kidney CD4+ TRM cells from healthy controls (Fig. 5d and Extended Data Fig. 8a), suggesting CD4+ TRM cells in patients with ANCA-GN could have higher mRNA translation efficiency. Of note, cytokine-responsive genes, such as CXCL1, CXCL5, CXCL9 and CXCL10 (Extended Data Fig. 3c), were highly expressed in the kidney tissue from patients with ANCA-GN compared to healthy controls (Fig. 5e). These findings suggested that enhanced cytokine mRNA translation contributed to T cell-mediated tissue damage in glomerulonephritis. Similarly, scRNA-seq analysis of CD8+ T cells from these patients found a lower ISR score in kidney CD8+ TRM cells from patients with ANCA-GN compared to kidney CD8+ TRM cells from healthy controls (Extended Data Fig. 8b,c), indicating increased CD8+ TRM cell activation in kidneys from patients with ANCA-GN. Additionally, we analyzed a public scRNA-seq dataset of colon CD4+ T cells from healthy donors and patients with Crohn’s disease, an inflammatory bowel disease in which type 1 (for example, TNF) and type 3 (for example, IL-17) cytokines play key roles44. We identified two CD4+SELLCCR7S1PR1KLF2 TRM cell clusters, a TNFhi CD4+ TRM cell subset and an IL17Ahi CD4+ TRM cell subset (Fig. 5f). The expression of mRNA encoding inflammatory cytokines (IL2, IL17A, IL17F, IL22, IFNG, TNF, CSF2 and LTA) in CD4+ TRM cells was comparable between healthy controls and patients with Crohn’s disease (Fig. 5g). Both TNFhi CD4+ TRM cells and IL17Ahi CD4+ TRM cells from patients with Crohn’s disease exhibited downregulation of the cellular response to stress pathway and lower ISR scores compared to healthy controls (Fig. 5h,i and Extended Data Fig. 8d). In the colon tissue from patients with Crohn’s disease, various cytokine-responsive genes were upregulated compared to healthy controls (Fig. 5j), indicating active cytokine mRNA translation in inflamed colon tissue. These findings suggested the potential downregulation of the ISR pathway as a mechanism to enhance the production of effector molecule proteins, resulting in increased tissue inflammation.

Fig. 5: The integrated stress response pathway is downregulated in TRM cells in patients with inflammatory diseases.
figure 5

a, UMAP plot showing the distribution of CD4+KLF2CD69+ TRM cells, CD4+SELL KLF2+CD69 TEM cells and CD4+SELL+KLF2+CD69 TCM/TN cells isolated from the kidney of healthy controls (n = 3) and patients with ANCA-GN (n = 5) (left) and heatmap showing the expression of CD69, CCR7, CD62L and CD45RA protein and KLF2, S1PR1, CCR7, SELL, IFNG, TNF, IL17A, IL17F and CSF2 mRNA in the CD4+ TRM, TEM and TCM/TN cell clusters defined in the UMAP (right). b, Violin plot showing cytokine scores based on the expression of IL2, IL17A, IL17F, IL22, IFNG, TNF, CSF2 and LTA in kidney CD4+ TRM cells from healthy controls and patients with ANCA-GN as in a. c, Reactome analysis showing downregulated pathways in kidney CD4+ TRM cells from patients with ANCA-GN compared to kidney CD4+ TRM cells from healthy controls. d, Violin plot showing ISR-associated gene scores based on the expression of PPP1R15A, PPP1R15B, ATF3, ATF4, ATF5, ATF6, DDIT3, DNAJB1, DUSP1, FOS, JUN, FOSB and JUNB in kidney CD4+ TRM cells from patients with ANCA-GN and healthy controls. e, Violin plot showing cytokine-responsive gene scores based on transcriptome data of kidney biopsies from patients with ANCA-GN (n = 22) and healthy controls (n = 21)26. f, UMAP plot showing the distribution of CD4+S1PR1IL17Ahi TRM cells, CD4+SELLS1PR1TNFhi TRM cells, CD4+SELLS1PR1+ TEM cells and CD4+SELL+S1PR1+ TCM/TN cells isolated from the colon of healthy controls (n = 2) and patients with Crohn’s disease (n = 2) (left) and heatmap showing the expression of KLF2, S1PR1, CCR7, SELL, RORC, IL17A, IL22 and TNF mRNA in CD4+ TCM/TN, TEM, TNFhi TRM and IL17Ahi TRM cells (right). g, Violin plot showing cytokine scores in colon CD4+TNFhi and CD4+IL17Ahi TRM cells from healthy controls and patients with Crohn’s disease as in f. h, Reactome analysis showing pathways downregulated in colon CD4+TNFhi and CD4+IL17Ahi TRM cells from patients with Crohn’s disease compared to colon CD4+TNFhi and CD4+IL17Ahi TRM cells from healthy controls as in f. i, Violin plots showing ISR-associated gene scores in colon CD4+TNFhi and CD4+IL17Ahi TRM cells from healthy controls and patients with Crohn’s disease as in f. j, Violin plot showing cytokine-responsive gene scores based on transcriptome data of colon biopsies from patients with Crohn’s disease (n = 92) and healthy controls (n = 55). Data are mean + s.e.m. Statistical analysis was performed using unpaired two-tailed t-test with Welch’s correction (d,e,i,j); **P < 0.01.

Full size image

In this study, we identified CD4+ TRM cells as the primary TM cell subset that stored untranslated cytokine mRNA. We showed that the ISR pathway and its mediator p-eIF2α facilitated the mRNA storage thereby suppressing its translation, and that the stored mRNA was sufficient for the rapid cytokine production upon activation. Different mechanisms of translation regulation have been reported. How the ISR pathway synergizes with other mechanisms, such as RNA-binding proteins21,45, the mTOR pathway46 or regulation of mRNA half-life21,47, remains unclear. While enhancing ISR with chemical compounds or gene overexpression significantly reduced cytokine production in mouse kidney CD4+ TRM cells, the marginal effects of ISRIB on cytokine production in these cells suggested that other pathways also regulate cytokine mRNA translation in CD4+ TRM cells. Overall, our findings suggested that the ISR–eIF2α pathway regulates cytokine mRNA translation in CD4+ TRM cells during homeostasis, and identified this pathway as a potential therapeutic target in T cell-mediated inflammatory diseases where ISR-mediated regulation is impaired.

Methods

Human studies

Human kidney tissue was obtained from n = 8 donors (included in the cohort 1) and n = 5 donors (included in the cohort 2) registered to the Hamburg GN Registry; n = 21 healthy donors, n = 22 patients with ANCA-GN, n = 32 patients with lupus nephritis and n = 27 patients with IgA nephropathy registered to the European Renal cDNA Bank26; and from n = 5 patients (included in cohort 3) registered to the Clinical Research Unit 228 (CRU 228) ANCA-GN cohort. For the eight donors in cohort 1 and the five donors in cohort 2, matched blood samples from the same donors were also analyzed for this study. Kidney T cells isolated from the healthy part of kidneys removed as part of tumor nephrectomy were considered as T cells at steady state. The histological examination confirmed that the healthy part of the kidney did not exhibit any signs of tumor invasion or active immune cell invasion. The research studies were conducted with the approval of the Ethik-Kommission der Ärztekammer Hamburg (the local ethics committee of the Chamber of Physicians in Hamburg) and in compliance with the ethical principles outlined in the Declaration of Helsinki. All participating patients gave informed consent for the research.

Mouse experiments

Experiments with mice followed the national guidelines, and local ethics committees (Behörde für Justiz und Verbraucherschutz Hamburg) approved the research protocols. Mice were housed under specific-pathogen-free conditions to ensure the validity and reliability of the experiments. Age-matched C57BL/6 male mice (between 8 and 16 weeks of age) were used in all experiments to minimize the variability between subjects. Il17aCreR26eYFP male mice32 between 8 and 16 weeks of age were used to identify TRM17 cells. For the induction of IL-17AMI and WTMI mice models, Il17aCreR26eYFP or wild-type C57BL/6 mice were intravenously injected with 1 × 107 S.aureus (strain SH100013) in 100 μl sterile PBS. For pathogen and inflammation clearance, ampicillin was given in drinking water for 2 weeks13 and mice were analyzed 2 months after the completion of the antibiotic treatment. Experimental crescentic glomerulonephritis was induced by intraperitoneal administration of sheep nephrotoxic serum targeting the glomerular basement membrane13. The cGNMI mice model was induced by administration of the sheep nephrotoxic serum into WTMI mice models. Raphin1 was reconstituted in distilled water with 0.5% methylcellulose (Sigma, M0512) and administered twice a day by oral gavage.

Histopathology, immunohistochemistry and immunofluorescence

To evaluate glomerular crescent formation, 30 glomeruli per mouse were assessed in a blinded manner in PAS-stained paraffin sections of kidneys13. For immunofluorescence staining, primary antibodies, including CD3 (A0452, Dako), Phospho-eIF2α (MA5-32021, Invitrogen), total eIF2α (D7D3, Cell Signaling) and Tia1 (ab140595, Abcam) were incubated in blocking buffer at 4 °C for 1 h. Following PBS washing, fluorochrome-labeled secondary antibodies were applied, and the staining was visualized using an LSM800 with Airyscan and the ZenBlue software (all Carl Zeiss).

To detect mRNA (FISH) in mice and human kidney sections, RNAscope Multiplex Fluorescent Assay (Advanced Cell Diagnostics) was employed. mRNA detection (FISH) in sorted T cells was carried out using the ViewRNA Cell Plus Assay kit (cat. no. 88-19000, Invitrogen). The slides were imaged using a Zeiss LSM800 confocal microscope and analyzed with ZEN software (Carl Zeiss). To evaluate Il17a mRNA in stress granules, the percentage of Il17a signals overlapping with Tia1-positive granules was calculated.

Isolation and flow cytometric analysis of human and murine leukocytes

Single-cell suspensions were obtained from kidney and blood samples to isolate and analyze human leukocytes. Kidney tissue was enzymatically digested with collagenase D at 0.4 mg ml−1 (Roche) and DNase I (10 μg ml−1, Sigma-Aldrich) in RPMI 1640 medium at 37 °C for 30 min, followed by dissociation with gentleMACS (Miltenyi Biotec). Blood samples were separated using Leucosep tubes (Greiner Bio-One). Samples were filtered through a 30-μm filter (Partec) before antibody staining and flow cytometry.

Cells from murine spleens were isolated by squashing the organ through a 70-µm cell strainer. Erythrocytes were lysed using a lysis buffer (155 mM NH4Cl, 10 mM KHCO3 and 10 µM EDTA, pH 7.2). To isolate renal lymphocytes from mice, kidneys were enzymatically digested with 400 µg ml−1 collagenase D (Roche) and 10 U ml−1 DNase I (Sigma-Aldrich) at 37 °C for 30 min. Subsequently, leukocytes were isolated by density gradient centrifugation using 37% Easycoll (Merck Millipore) and a filtration step using a 30-µm cell strainer (Partec). T cell isolation from the intestine is described previously. In brief, murine intestine was cut longitudinally after removing Peyer’s patches and adventitial fat. To collect intraepithelial lymphocytes, the intestine tissue was incubated in HBSS containing 1 mM dithiothreitol (DTT) followed by a dissociation step using 1 mM EDTA for 20 min at 37 °C. To collect lamina propria lymphocytes, the tissue was cut into small pieces and incubated for 45 min at 37 °C in HBSS supplied with 1 mg ml−1 collagenase and 10 U ml−1 DNase I. Leukocytes were further enriched by Percoll gradient. Intraepithelial cells and lamina propria lymphocytes were pooled for analysis.

Cells were surface stained with fluorochrome-conjugated antibodies (human, CD45 (HI30, BD Biosciences), CD3 (OKT3, eBioscience), CD4 (RPA-T4, BD Biosciences), CD8 (RPA-T8, BD Biosciences), CD69 (FN50, BD Biosciences), CD45RA (HI100, BD Biosciences), GM-CSF (VD2-21C11, BD Biosciences), IL-17A (BL168, BioLegend), IL-17F (SHLR17, BioLegend), IFNγ (4S.B3, eBioscience), TNF (MAB11, BD Biosciences), CCR7/CD197 (Go43H7, BD Biosciences); mouse, CD45 (30-F11, BD Biosciences), CD3 (145-2C11, BD Biosciences), CD4 (RM4-5, BD Biosciences), CD8 (53-6.7, BD Biosciences), GM-CSF (MP1-22E9, BD Biosciences), IL-17A (TC11-18H10, BD Biosciences), IL-17F (9D3.1C8, BioLegend), IL-22 (poly5164, BioLegend), IFNγ (XMG1.2, BD Biosciences), TNF (MP6-XT22, BD Biosciences)) and a fixable dead-cell stain (Molecular Probes) to exclude dead cells from the analysis. For intracellular staining, samples were processed using Cytofix/Cytoperm (BD Biosciences) according to the manufacturer’s instructions. All antibodies were diluted at a ratio of 1:100 to 1:200.

To assess the phospho-eIF2α and total eIF2α levels, isolated T cells were stimulated with CD3/28 antibodies for 2–3 days, and transferred to unstimulated conditions. For re-stimulation, T cells were further stimulated with PMA + Iono or CD3 + CD28 antibodies. Stimulated and unstimulated T cells underwent surface staining and were subsequently fixed and permeabilized using Foxp3/Transcription Factor Staining Buffer (eBioscience). The cells were then incubated with primary antibodies directed against phospho-eIF2α or total eIF2α (1:1,000 dilution) for 40 min. After two rounds of washing, the cells were exposed to a secondary antibody conjugated with AF647 against Rabbit IgG (1:1,000 dilution) for 40 min.

Ca2+ live-cell imaging in murine T cells

Freshly isolated primary murine CD4+ T cells were loaded with Fura2-AM (4 µM) and incubated for 40 min at 37 °C. Following the loading process, the cells were washed twice and resuspended in Ca2+ buffer comprising 140 mM sodium chloride (NaCl), 5 mM potassium chloride (KCl), 1 mM magnesium sulfate (MgSO4), 1 mM calcium chloride (CaCl2), 20 mM 4-(2-hydroxyethyl)-1 piperazine ethanesulfonic acid (HEPES), 1 mM sodium dihydrogen phosphate (NaH2PO4) and 5.5 mM glucose at pH 7.4. Imaging was conducted using a Leica IRBE microscope with a ×40 magnification and an exposure of 25 ms. The microscope was equipped with a Sutter DG-4 as a light source and an electron-multiplying charge-coupled device camera (EMCCD; 13, Hamamatsu). The images were acquired in 16-bit mode with an acquisition rate of one frame every 2 s, using Volocity software (v.6.6.2; PerkinElmer). The following filter set for Fura2 was used (excitation filters, HC 340/26, HC 387/11; beamsplitter, 400 DCLP; emission filter, 510/84, all in nanometers). At 5 min before acquisition, the T cells were incubated with either 10 μM Sal003 (Sigma-Aldrich, S4451), 20 μM Sephin1 (Sigma-Aldrich, SML1356), 20 μM Raphin1 (Sigma-Aldrich, SML2562), 500 μM NaAsO2 (Sigma-Aldrich, S7400) or Ca2+ buffer and dimethylsulfoxide (DMSO) (as control). T cell stimulation was initiated through the addition of soluble anti-CD3 antibody (10 µg ml−1) after 1 min. Subsequently, the background correction, splitting of fluorescence channels and selection of cells into regions of interest were performed with Fiji v.2. Furthermore, to obtain the Ca2+ concentration from ratio values, a calibration was calculated by measuring the maximal ratio value (Rmax) and the minimal ratio value (Rmin). The mean Ca2+ concentration over time as well as the mean basal (after 30 s), peak (at 260 s) and plateau (at 520 s) Ca2+ concentration were calculated using Prism10.

Flow cytometry and cell sorting

Samples were measured with LSR II or Symphony A3 (both BD Biosciences). Data analysis was performed using FlowJo software (TreeStar). FACS sorting was performed with an AriaFusion or AriaIIIu (BD Biosciences).

Quantitative RT–PCR

T cells were subjected to RNA extraction utilizing the RNeasy Micro kit (QIAGEN). RNA from the renal cortex was isolated with the NucleoSpin kit (Macharey-Nagel) in compliance with the manufacturer’s recommended protocol. Subsequently, the RNA underwent reverse transcription using the High-Capacity cDNA Reverse Transcription kit (Thermo Fisher), and the StepOnePlus Real-Time PCR system (Thermo Fisher) was utilized for measurement. The Taqman primers used for human IL17A, IFNG, CSF2, ZC3H12D, ATF4, 18S rRNA and murine Il17a were procured from Life Technologies.

In vitro stimulation of cells

Human and murine T cells were classified based on the surface markers and FACS sorted before stimulation. TRM cells were characterized as CD45+CD4+CD44+CD69+CD62L; TEM cells as CD45+CD4+CD44+CD69CD62L; TCM cells as CD45+CD4+CD44+CD69CD62L+; and naive T cells as CD45+CD4+CD44CD69CD62L+. The cells were exposed to PMA (50 ng ml−1, Sigma-Aldrich) and Iono (1 μM, Sigma-Aldrich) for T cell activation. To detect cytokine production, brefeldin A (10 μg ml−1, Sigma-Aldrich) was added to inhibit cytokine secretion from cells. After 3–6 h, cytokine production was measured using intracellular staining and flow cytometry techniques. To inhibit de novo mRNA transcription, 20 µg ml−1 actinomycin D (A1410, Sigma-Aldrich) was added to the medium 10 min before T cell stimulation. For ex vivo stimulation to measure eIF2α levels, 1–2 × 106 TRM cells were cultured in a volume of 300 μl IMDM containing 10% FCS, streptomycin and penicillin in a 96-well plate pre-coated with anti-CD3 antibody (2 μg ml−1, BioLegend 100360), along with the addition of 5 μg ml−1 anti-CD28 antibody (BioLegend 102122) for a duration of 2 days. To induce the ISR, T cells were incubated with 10 μM Sal003 (Sigma-Aldrich, S4451), 20 μM Sephin1 (Sigma-Aldrich, SML1356), 20 μM Raphin1 (Sigma-Aldrich, SML2562) or 500 μM NaAsO2 (Sigma-Aldrich, S7400). For the experiment using ISRIB, ex vivo-cultured TRM cells isolated from the kidney were treated with 500 nM ISRIB (Sigma, SML0843) overnight and analyzed for the production of cytokines.

Puromycin incorporation assay

T cells were cultured in the presence or absence of PMA (50 ng ml−1, Sigma-Aldrich) and Iono (1 μM, Sigma-Aldrich) for 1 h. Puromycin (5 μg ml−1, Sigma-Aldrich) was added in the last 10 min. Cells were washed and stained for surface markers and fixable dead-cell stain and then fixed and permeabilized using Foxp3/Transcription Factor Staining Buffer (eBioscience). Puromycin was detected using anti-puromycin-AF647 (MABE343 clone 12D10, Sigma-Aldrich).

Polysome profiling for mRNA translation efficiency analysis

Polysome profiling and mRNA extraction were conducted as described previously30. Human TRM cells sorted from healthy human kidney tissue were mixed with two million NIH/3T3 cells because the number of human TRM cells was insufficient to show monosome peaks. We relied on monosome peaks from a murine cell line because monosome peaks were observed with the same kinetics in humans and mice. Cells were lysed in 250 μl cell lysis buffer (10 mM Tris-HCl (pH 7.4), 5 mM MgCl2, 100 mM KCl, 1% Triton X-100, 2 mM DTT and 100 μg ml−1 cycloheximide). Cells were shear-opened with a 26-gauge needle by passing the lysate eight times through it. A quantity of 300 μl of the cell lysate was loaded onto a 5-ml sucrose gradient (60% to 15% sucrose) dissolved in polysome buffer (50 mM HEPES-KOH, pH 7.4, 5 mM MgCl2, 100 mM KCl, 2 mM cycloheximide and 2 mM DTT) and separated by ultracentrifugation at 148,900g (Ti55 rotor, Beckman) for 1.5 h at 4 °C. Polysome fractions and nonpolysome fractions were collected separately. RNA was extracted from each fraction by adding 0.1 volume of 10% SDS and one volume of acidic phenol–chloroform (5:1, pH 4.5), incubated at 65 °C for 5 min, and centrifuged at 21,000g for 5 min at 4 °C to separate different phases. Equal volumes of acid phenol–chloroform were added to the aqueous phase, separated by centrifugation and supplemented with an equal volume of chloroform:isoamyl alcohol (24:1). Upon separation, the aqueous phase was supplemented with 0.1 volume 3 M NaOAc (pH 5.5) and an equal volume of isopropanol, precipitated at −20 °C for 3 h. RNA was pelleted at 21,000g at 4 °C, and the dried pellets were resuspended in water. RNA was subjected to RT–qPCR analysis and the original mRNA amount in polysome and nonpolysome fractions was calculated by RT–qPCR using Taqman primers specific to human mRNA. mRNA translation efficiency was defined as the amount of mRNA in polysome fraction divided by the total mRNA amount of nonpolysome and polysome fractions.

Retrovirus transduction and cell transfer into Rag1 KO mice

MIGR1 plasmid48 (produced by W. Pear, Addgene plasmid #27490) was used to overexpress eIF2α variants. Both eIF2α variants, S51A and S51D, were inserted into EcoRI-digested MIGR1 backbone. To produce retrovirus, HEK293T cells were seeded into a six-well plate and, the next day, transfected with MIGR1-eIF2α variant plasmid and pCL-Eco plasmid49 (Produced by Inder Verma, Addgene plasmid #12371) using Lipofectamine 3000 (Invitrogen L3000001). Murine T cells were stimulated in a 24-well plate (2 × 106 cells per well) for 2 days using anti-CD3 antibody (2 μg ml−1, BioLegend, 100360) and anti-CD28 antibody (5 μg ml−1, BioLegend, 102122). After the 2-day stimulation, the medium was replaced with virus-containing medium with supplementation of Polybrene. Cells were centrifuged at 1,000g, room temperature for 1 h. The next day, green fluorescent protein-positive T cells were sorted using FACS and transferred into Rag1 KO mice (105 cells per mouse). Following T cell reconstitution, mice were challenged by the cGN model.

Single-cell RNA sequencing

To carry out scRNA-seq, single-cell suspensions were derived from human and mouse kidney samples. Cell hashing was implemented according to the manufacturer´s instructions (BioLegend). For CITE-seq, monoclonal antibodies with corresponding barcodes were applied to samples (BioLegend). FACS-sorted CD45+ cells or CD3+ T cells were subjected to droplet-based single-cell analysis and transcriptome library preparation using Chromium Single-Cell 5′ Reagent kits v2 according to the manufacturer’s protocols (10x Genomics). The generated scRNA-seq libraries were subjected to sequencing on a NovaSeq6000 system (100 cycles) (Illumina).

Alignment, quality control and pre-processing of scRNA-seq data

Quality control and scRNA-seq pre-processing were carried out as previously described13. In brief, the Cell Ranger software pipeline (v.5.0.1, 10x Genomics) was utilized to perform the demultiplexing of cellular barcodes and mapping of reads to the reference genome (refdata-cellranger-hg19-1.2.0 (human) or refdata-gex-mm10-2020-A (mouse)). Seurat (v.4.0.2) demultiplexing function HTODemux was used to demultiplex the hash-tag samples. We filtered out the cells with <500 genes, >6,000 genes or >5% mitochondrial genes. For CITE-seq, a pseudo-reference genome was built with cellranger mkref function in Cell Ranger. CITE-seq raw data were aligned to this pseudo-reference genome using Cell Ranger function cellranger count. The antibody-derived tags data were integrated to scRNA-seq data using Seurat. Further information is described previously13.

Dimensionality reduction, clustering, enrichment analysis and scores

The Seurat package (v.4.0.2) was used to conduct unsupervised clustering analysis on scRNA-seq data. In brief, gene counts for cells were normalized by library size and log-transformed. To reduce batch effects, we employed the integration method implemented in the latest Seurat v.4 (function FindIntegrationAnchors and IntegrateData, dims of 1:30). The integrated matrix was then scaled by the ScaleData function (default parameters). To reduce dimensionality, principal-component analysis was performed on the scaled data (function RunPCA, npcs of 30). Thirty principal components were determined using the ElbowPlot function to compute the KNN graph based on the Euclidean distance (function FindNeighbors), which then generated cell clusters using the function FindClusters. UMAP was used to visualize clustering results. The top differential expressed genes in each cluster were found using the FindAllMarkers function (min.pct of 0.1) and running Wilcoxon rank-sum tests. The differential expression between clusters or groups was calculated by the FindMarkers function (min.pct of 0.1), which also included Wilcoxon rank-sum tests. For enrichment analysis including GO, Reactome, Canonical pathway and protein–protein interaction analyses, metascape50 was used. To calculate scores (RPG score and ISR score) in scRNA-seq data, Seurat function AddModuleScore was used. For both scores, all RPGs34 and ISR-associated genes31,38,39,40,41 listed in heatmaps (Extended Data Fig. 5) were included.

Data analysis, statistics and reproducibility

Statistical analysis was performed using GraphPad Prism. The results are shown as mean ± s.e.m. when presented as a bar graph or as single data points with the mean in a scatter-plot. Differences between the two individual groups were compared using a two-tailed t-test. In the case of three or more groups, a one-way ANOVA with Tukey’s multiple comparisons test was used. The correlation coefficient r was calculated using a Pearson correlation, and the corresponding P value was based on a t-distribution test. All experiments were repeated at least three times, except for some experiments with human cells, which were repeated twice as stated in the figure legends. No statistical methods were used to predetermine sample sizes but our sample sizes are similar to those reported in previous publications13. Data distribution was assumed to be normal but this was not formally tested. Data collection was not performed but data analysis was performed blind to the conditions of the experiments. We did not exclude any data points. For bioinformatics analysis, RStudio and Jupyter Notebook were used to execute code.

Reporting summary

Further information on research design is available in the Nature Portfolio Reporting Summary linked to this article.

Related Articles

Type 2 immunity in allergic diseases

Significant advancements have been made in understanding the cellular and molecular mechanisms of type 2 immunity in allergic diseases such as asthma, allergic rhinitis, chronic rhinosinusitis, eosinophilic esophagitis (EoE), food and drug allergies, and atopic dermatitis (AD). Type 2 immunity has evolved to protect against parasitic diseases and toxins, plays a role in the expulsion of parasites and larvae from inner tissues to the lumen and outside the body, maintains microbe-rich skin and mucosal epithelial barriers and counterbalances the type 1 immune response and its destructive effects. During the development of a type 2 immune response, an innate immune response initiates starting from epithelial cells and innate lymphoid cells (ILCs), including dendritic cells and macrophages, and translates to adaptive T and B-cell immunity, particularly IgE antibody production. Eosinophils, mast cells and basophils have effects on effector functions. Cytokines from ILC2s and CD4+ helper type 2 (Th2) cells, CD8 + T cells, and NK-T cells, along with myeloid cells, including IL-4, IL-5, IL-9, and IL-13, initiate and sustain allergic inflammation via T cell cells, eosinophils, and ILC2s; promote IgE class switching; and open the epithelial barrier. Epithelial cell activation, alarmin release and barrier dysfunction are key in the development of not only allergic diseases but also many other systemic diseases. Recent biologics targeting the pathways and effector functions of IL4/IL13, IL-5, and IgE have shown promising results for almost all ages, although some patients with severe allergic diseases do not respond to these therapies, highlighting the unmet need for a more detailed and personalized approach.

Iron homeostasis and ferroptosis in muscle diseases and disorders: mechanisms and therapeutic prospects

The muscular system plays a critical role in the human body by governing skeletal movement, cardiovascular function, and the activities of digestive organs. Additionally, muscle tissues serve an endocrine function by secreting myogenic cytokines, thereby regulating metabolism throughout the entire body. Maintaining muscle function requires iron homeostasis. Recent studies suggest that disruptions in iron metabolism and ferroptosis, a form of iron-dependent cell death, are essential contributors to the progression of a wide range of muscle diseases and disorders, including sarcopenia, cardiomyopathy, and amyotrophic lateral sclerosis. Thus, a comprehensive overview of the mechanisms regulating iron metabolism and ferroptosis in these conditions is crucial for identifying potential therapeutic targets and developing new strategies for disease treatment and/or prevention. This review aims to summarize recent advances in understanding the molecular mechanisms underlying ferroptosis in the context of muscle injury, as well as associated muscle diseases and disorders. Moreover, we discuss potential targets within the ferroptosis pathway and possible strategies for managing muscle disorders. Finally, we shed new light on current limitations and future prospects for therapeutic interventions targeting ferroptosis.

Targeting of TAMs: can we be more clever than cancer cells?

With increasing incidence and geography, cancer is one of the leading causes of death, reduced quality of life and disability worldwide. Principal progress in the development of new anticancer therapies, in improving the efficiency of immunotherapeutic tools, and in the personification of conventional therapies needs to consider cancer-specific and patient-specific programming of innate immunity. Intratumoral TAMs and their precursors, resident macrophages and monocytes, are principal regulators of tumor progression and therapy resistance. Our review summarizes the accumulated evidence for the subpopulations of TAMs and their increasing number of biomarkers, indicating their predictive value for the clinical parameters of carcinogenesis and therapy resistance, with a focus on solid cancers of non-infectious etiology. We present the state-of-the-art knowledge about the tumor-supporting functions of TAMs at all stages of tumor progression and highlight biomarkers, recently identified by single-cell and spatial analytical methods, that discriminate between tumor-promoting and tumor-inhibiting TAMs, where both subtypes express a combination of prototype M1 and M2 genes. Our review focuses on novel mechanisms involved in the crosstalk among epigenetic, signaling, transcriptional and metabolic pathways in TAMs. Particular attention has been given to the recently identified link between cancer cell metabolism and the epigenetic programming of TAMs by histone lactylation, which can be responsible for the unlimited protumoral programming of TAMs. Finally, we explain how TAMs interfere with currently used anticancer therapeutics and summarize the most advanced data from clinical trials, which we divide into four categories: inhibition of TAM survival and differentiation, inhibition of monocyte/TAM recruitment into tumors, functional reprogramming of TAMs, and genetic enhancement of macrophages.

Integrated proteogenomic characterization of ampullary adenocarcinoma

Ampullary adenocarcinoma (AMPAC) is a rare and heterogeneous malignancy. Here we performed a comprehensive proteogenomic analysis of 198 samples from Chinese AMPAC patients and duodenum patients. Genomic data illustrate that 4q loss causes fatty acid accumulation and cell proliferation. Proteomic analysis has revealed three distinct clusters (C-FAM, C-AD, C-CC), among which the most aggressive cluster, C-AD, is associated with the poorest prognosis and is characterized by focal adhesion. Immune clustering identifies three immune clusters and reveals that immune cluster M1 (macrophage infiltration cluster) and M3 (DC cell infiltration cluster), which exhibit a higher immune score compared to cluster M2 (CD4+ T-cell infiltration cluster), are associated with a poor prognosis due to the potential secretion of IL-6 by tumor cells and its consequential influence. This study provides a comprehensive proteogenomic analysis for seeking for better understanding and potential treatment of AMPAC.

Chemokine receptor CCR9 suppresses the differentiation of CD4+CD8αα+ intraepithelial T cells in the gut

The chemokine receptor CCR9 equips T cells with the ability to respond to CCL25, a chemokine that is highly expressed in the thymus and the small intestine (SI). Notably, CCR9 is mostly expressed on CD8 but not on CD4 lineage T cells, thus imposing distinct tissue tropism on CD4 and CD8 T cells. The molecular basis and the consequences for such a dichotomy, however, have not been fully examined and explained. Here, we demonstrate that the forced expression of CCR9 interferes with the tissue trafficking and differentiation of CD4 T cells in SI intraepithelial tissues. While CCR9 overexpression did not alter CD4 T cell generation in the thymus, the forced expression of CCR9 was detrimental for the proper tissue distribution of CD4 T cells in the periphery, and strikingly also for their terminal differentiation in the gut epithelium. Specifically, the differentiation of SI epithelial CD4 T cells into immunoregulatory CD4+CD8αα+ T cells was impaired by overexpression of CCR9 and conversely increased by the genetic deletion of CCR9. Collectively, our results reveal a previously unappreciated role for CCR9 in the tissue homeostasis and effector function of CD4 T cells in the gut.

Responses

Your email address will not be published. Required fields are marked *